Danoprevir has been used in trials studying the treatment of Hepatitis C, Chronic.
本品应与利托那韦、聚乙二醇干扰素α和利巴韦林联合组成抗病毒治疗方案,用于治疗初治的非肝硬化的基因1b型慢性丙型肝炎成人患者。
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.